Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 3:31 PM ET

Biotechnology

Company Overview of Sangamo Biosciences Inc.

Executive Profile

Edward O. Lanphier II

Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee, Sangamo Biosciences Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 2 different industries.

See Board Relationships
58$4,784,225
As of Fiscal Year 2014

Background

Mr. Edward O. Lanphier, II, founded Sangamo BioSciences Inc. and has been its President and Chief Executive Officer since 1995. Mr. Lanphier has been the Chairman of Executive Committee at Alliance for Regenerative Medicine since December 31, 2014. From June 1992 to May 1997, Mr. Lanphier served in various positions with Somatix Therapy Corporation, including Executive Vice President of Commercial Development and Chief Financial Officer. He served as the President and ...

Corporate Headquarters

501 Canal Boulevard
Richmond, California 94804

United States

Phone: 510-970-6000
Fax: 510-236-8951

Board Members Memberships

Director
Director
Director
1995-Present
Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee

Education

BA
Knox College

Other Affiliations

Annual Compensation

Salary$650,000
Total Annual Compensation$650,000

Stocks Options

Restricted Stock Awards$1,758,750
Exercised Options$300,000
Exercised Options Value$3,442,735
Exercisable Options$1,562,500
Exercisable Options Value$13,253,375
Unexercisable Options$487,500
Unexercisable Options Value$1,857,625
Total Value of Options$18,553,735
Total Number of Options$2,350,000

Total Compensation

Total Annual Cash Compensation$1,001,000
Total Short Term Compensation$650,000
Other Long Term Compensation$1,758,750
Total Calculated Compensation$4,784,225
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Nick Leschly Chief Executive Officer, President and Director
bluebird bio, Inc.
$440.4K
André Choulika Ph.D.Co-Founder, Chairman and Chief Executive Officer
Cellectis S.A.
$328.4K
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
Jörn Aldag Chief Executive Officer, Managing Director and Member of Management Board
uniQure N.V.
$484.0K
Jeffrey D. Marrazzo M.B.A., M.P.A.Co-Founder, Chief Executive Officer and Director
Spark Therapeutics, Inc.
$349.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sangamo Biosciences Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.